Drug to treat movement symptoms of HD approved by FDA

This installment of HDYO Research Video Series focuses on the recent HD Buzz article focusing on the recent FDA approval of INGREZZA to treat movement symptoms in Huntington's Disease.

To read the complete article, visit https://en.hdbuzz.net/348

The Research Video Series is sponsored by Teva Pharmaceutical, uniQure, The Griffin Foundation, Neurocrine Biosciences, Sage Therapeutics and Roche.